Mirum Pharmaceuticals prices notes worth $275M

Mirum Pharmaceuticals (NASDAQ:MIRM) prices its offering of $275M aggregate principal amount of 4.00% convertible senior notes due 2029 in a private offering.
The offering size was increased from the previously announced offering size of $200M aggregate principal amount of notes.
The issuance and sale of the notes are scheduled to settle on April 17, 2023.
Mirum also granted the initial purchasers up to an additional $41.25M principal amount of notes.
The notes will be senior, unsecured obligations of Mirum and will accrue interest at a rate of 4.00% per annum, payable semi-annually in arrears on May 1 and November 1 of each year, beginning on November 1, 2023.
Net proceeds to be deployed for general corporate purposes, including working capital, operating expenses and capital expenditures.